-

ORPEA Group: Mr Philippe Charrier, Chairman and CEO, Responds to Mirova's Letter

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News:

In my capacity as Chairman of the Board of Directors, I would like to thank Mirova for its letter dated 7 February. ORPEA (Paris:ORP) fully shares the concerns raised in this letter.

Please rest assured that we continue to be fully committed to the proper and caring treatment of our residents, patients, families and employees.

We too are convinced that end-of-life care is a major social issue where the private sector must complement public action.

I also welcome the constructive proposals made in this letter.

I undertake to submit to the Board of Directors and its competent committees all the proposals made and I will ensure that a response is given to the questions raised.

ORPEA wishes to point out that its Board of Directors has already taken all the necessary steps to shed light on the allegations made against the Group.

In particular, two independent world-renowned firms have been mandated to carry out the necessary assessments within the Group, the conclusions of which will be the subject of a specific communication to the market and the Board of Directors will draw all the necessary conclusions in the interest of all stakeholders.

Philippe CHARRIER
Chairman and CEO

Contacts

ORPEA Group

ORPEA Group

BOURSE:ORP

Release Versions

Contacts

ORPEA Group

More News From ORPEA Group

emeis: Availability of the 2026 Half-Year Financial Report

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS):  emeis filed, today, its half-year financial report for the period starting on 1 January 2026 and ending on 30 June 2026, with the French Autorité des Marchés Financiers. The half-year report can be consulted and downloaded from the Company’s website at: https://www.emeis.com/en/investors-shareholders/financial-information-and-publications/universal-registration-document. It is also available at the Company’s headquarter (e...

emeis: 2026 Half-Year Results

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS): Strong performance across all of the Group’s markets Revenue rose sharply by +6.0% on a like-for-like basis, representing an increase of +€103 million … particularly in Nursing Homes at +7.1% (clinics at +4.1%) and internationally at +7.5% (France at +3.7%) Occupancy rates rose by an average of +2.8 points (to 89.8%) and exceeded 90% in the second quarter alone, driven by improved sales performance (a +22% increase in the n...

emeis: Half-Year Review (H1 2026) of the Liquidity Agreement Entered Into With Natixis Oddo BHF

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: Under the liquidity agreement entrusted by emeis (the “Company”) (Paris:EMEIS) to Natixis Oddo BHF, the following resources were recorded in the dedicated liquidity account as of 30 June 2026: - 83,573 shares - €1,033,935 in cash During the 2026 first half-year, it was carried out a total of: PURCHASE 2,398 transactions 1,055,480 shares €15,046,731 SALE 2,313 transactions 1,042,872 shares €14,968,979 It is reminded that as of the last half-year...
Back to Newsroom